A family case narrative and recent research highlight how EEG-guided rTMS is being studied in autism research.
WIMBERLEY, TX, UNITED STATES, December 30, 2025 /EINPresswire.com/ — Brain Treatment USA has released an expanded case narrative and research summary to help clarify how repetitive transcranial magnetic stimulation (rTMS) and EEG-guided rTMS (also referred to as MeRT or Magnetic e-Resonance Therapy) approaches are being evaluated in autism research. The update comes amid growing public interest in noninvasive brain-based interventions and the role they may play in advancing understanding of brain-based differences in autism.
A recently published narrative from BrainCare Performance Center Carlsbad describes one family’s search for solutions for their son, Ahmed, who experienced long-standing challenges with communication and emotional regulation. According to the report, Ahmed’s father noted that daily interactions often felt unpredictable and that common interventions had not fully addressed the family’s concerns. After undergoing quantitative electroencephalography (qEEG) to assess Ahmed’s brain activity, clinicians used the findings to guide individualized stimulation parameters for EEG-guided rTMS sessions.
Throughout the course of treatment, Ahmed’s father reported observing changes in his son’s attention, engagement, and ease of interaction—observations he described as meaningful for their family. In recounting his family’s experience, Ahmed’s father emphasized that his observations reflect a personal perspective rather than a clinical outcome. As he stated in an interview reflecting on his experience:
“This is probably the only therapy that I have seen in my nine years of parenthood that has brought change in him. There is a significant, noticeable change. I could say that Ahmed has developed, has achieved a milestone, has grown from last year. He has become a different person.”
These experiences reflect a single family’s perspective and are not indicative of broader outcomes, but they provide insight into how some parents describe their experiences with emerging neuromodulation approaches.
rTMS is a noninvasive procedure that uses magnetic pulses to influence cortical activity. It is FDA-cleared for conditions such as major depressive disorder and obsessive-compulsive disorder. Its use in autism, however, is currently a subject of ongoing scientific research. EEG-guided rTMS—sometimes referred to as Magnetic e-Resonance Therapy (MeRT)—incorporates qEEG to help clinicians identify patterns in brain activity and tailor stimulation parameters accordingly.
Recent literature has increasingly examined how TMS may influence neural connectivity and behavior in autistic individuals. Researchers note promising findings while also emphasizing the need for continued controlled studies.
A 2024 systematic review examined all published studies using TMS to treat ASD between 2018 and 2023. The researchers analyzed each study’s design, treatment parameters, stimulation targets, localization methods, behavioral outcomes, and neuroimaging findings. Per their report:
“After TMS intervention, discernible enhancements across a spectrum of scales are evident in stereotyped behavior, repetitive behavior, and verbal social domains. A comprehensive review of literature spanning the last five years demonstrates the potential of TMS treatment for ASD in ameliorating the clinical core symptoms.”
Additional summaries compiled by Brain Treatment USA’s partner clinics bring together findings from multiple pilot studies and clinical investigations.
Brain Treatment USA notes that rTMS applications in autism are still being evaluated in ongoing research. The organization’s goal in releasing this summary is to support informed public discussion and highlight areas of active scientific inquiry that continue to shape future research directions.
About Brain Treatment USA
Brain Treatment USA supports a network of independently operated clinics specializing in noninvasive neuromodulation. These clinics provide FDA-cleared rTMS for depression and related conditions and participate in ongoing evaluations of EEG-guided rTMS approaches being studied in autism research. Brain Treatment USA does not make claims regarding the efficacy of investigational therapies.
Trina Tew
Brain Treatment USA
+1 210-346-0282
info@braintreatmentusa.com
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
